FDA Approval Activities for this Drug…

Dacarbazine for Injection USP, 200 mg/vial, Faulding Pharmaceutical Co. ANDA 75-940 10/18/01 4/16/03 Dacarbazine for Injection USP, 500 mg/vial, Bedford ANDA 75-812/S3 10/31/02 Dacarbazine for Injection USP, 200 mg/vial, Bedford ANDA 75-812 6/15/01 6/26/01 Dacarbazine for Injection USP, 100 mg/vial & 200 mg/vial American Pharmaceutical Partners, ANDA 75-371 8/27/99 9/2/99 Dacarbazine for Injection USP, 200 mg/vial, Gensia Sicor ANDA 75-259 DACARBAZINE Injection 100MG/VIAL DACARBAZINE AM PARTNERS 075371 DACARBAZINE Injection 200MG/VIAL DACARBAZINE AM PARTNERS 017575 DACARBAZINE Injection 100MG/VIAL DTIC-DOME BAYER 017575 DACARBAZINE Injection 200MG/VIAL DTIC-DOME BAYER 075812 DACARBAZINE Injection 200MG/VIAL DACARBAZINE Bedford 075812 DACARBAZINE Injection 500MG/VIAL DACARBAZINE Bedford 075940 DACARBAZINE Injection 200MG/VIAL DACARBAZINE Faulding 075259 DACARBAZINE Injection 200MG/VIAL DACARBAZINE Gensia Sicor 075259 DACARBAZINE Injection 500MG/VIAL DACARBAZINE Gensia Sicor

For the latest approval information, please locate this drug using this index.